Translational studies of lipoprotein-associated phospholipase A 2 in inflammation and atherosclerosis

Journal of the American College of Cardiology

Volumn 59, Issue 8, 2012, Pages 764-772

  Ferguson, Jane F ^a   Hinkle, Christine C ^a   Mehta, Nehal N ^a   Bagheri, Roshanak ^a   Derohannessian, Stephanie L ^a   Shah, Rhia ^a   Mucksavage, Megan I ^a   Bradfield, Jonathan P ^b   Hakonarson, Hakon ^b   Wang, Xuexia ^a   Master, Stephen R ^a   Rader, Daniel J ^a   Li, Mingyao ^a   Reilly, Muredach P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

coronary artery calcification; lipoprotein associated phospholipase A 2; PLA2G7

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; C REACTIVE PROTEIN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ADULT; ARTICLE; ATHEROGENESIS; CELL DIFFERENTIATION; CELL LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CALCIFICATION; DISEASE ASSOCIATION; ENDOTOXEMIA; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PLA2G7 GENE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE TRAIT LOCUS MAPPING; SINGLE NUCLEOTIDE POLYMORPHISM;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ADULT; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84863157847     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.11.019     Document Type: Article

References (48)

1. A. Zalewski, C. Macphee Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target Arterioscler Thromb Vasc Biol 25 2005 923 931 (Pubitemid 40627835)
2. R.L. Wilensky, C.H. Macphee Lipoprotein-associated phospholipase A(2) and atherosclerosis Curr Opin Lipidol 20 2009 415 420
3. J.Y. Kim, Y.J. Hyun, Y. Jang Lipoprotein-associated phospholipase A2 activity is associated with coronary artery disease and markers of oxidative stress: a case-control study Am J Clin Nutr 88 2008 630 637
4. L.B. Daniels, G.A. Laughlin, M.J. Sarno, R. Bettencourt, R.L. Wolfert, E. Barrett-Connor Lipoprotein-associated phospholipase A2 is an independent predictor of incident coronary heart disease in an apparently healthy older population: the Rancho Bernardo Study J Am Coll Cardiol 51 2008 913 919 (Pubitemid 351282456)
5. E.R. Mohler 3rd, C.M. Ballantyne, M.H. Davidson Darapladib Investigators The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study J Am Coll Cardiol 51 2008 1632 1641 (Pubitemid 351635837)
6. P.W. Serruys, H.M. Garcia-Garcia, P. Buszman Integrated Biomarker and Imaging Study 2 Investigators Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque Circulation 118 2008 1172 1182
7. R.L. Wilensky, Y. Shi, E.R. Mohler 3rd Inhibition of lipoprotein- associated phospholipase A2 reduces complex coronary atherosclerotic plaque development Nat Med 14 2008 1059 1066
8. C.C. Tellis, A.D. Tselepis The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma Biochim Biophys Acta 1791 2009 327 338
9. 2 Studies Collaboration Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies Lancet 375 2010 1536 1544
10. T. Hakkinen, J.S. Luoma, M.O. Hiltunen Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions Arterioscler Thromb Vasc Biol 19 1999 2909 2917 (Pubitemid 30029817)
11. F.D. Kolodgie, A.P. Burke, K.S. Skorija Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis Arterioscler Thromb Vasc Biol 26 2006 2523 2529 (Pubitemid 44607475)
12. M. Lehrke, M.P. Reilly, S.C. Millington, N. Iqbal, D.J. Rader, M.A. Lazar An inflammatory cascade leading to hyperresistinemia in humans PLoS Med 1 2004 e45
13. P.D. Anderson, N.N. Mehta, M.L. Wolfe Innate immunity modulates adipokines in humans J Clin Endocrinol Metab 92 2007 2272 2279 (Pubitemid 46997133)
14. M.P. Reilly, M.L. Wolfe, A.R. Localio, D.J. Rader C-reactive protein and coronary artery calcification: the Study of Inherited Risk of Coronary Atherosclerosis (SIRCA) Arterioscler Thromb Vasc Biol 23 2003 1851 1856 (Pubitemid 37254874)
15. M.P. Reilly, N. Iqbal, M. Schutta Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes J Clin Endocrinol Metab 89 2004 3872 3878 (Pubitemid 39071487)
16. A.S. Agatston, W.R. Janowitz, F.J. Hildner, N.R. Zusmer, M. Viamonte Jr., R. Detrano Quantification of coronary artery calcium using ultrafast computed tomography J Am Coll Cardiol 15 1990 827 832 (Pubitemid 20101575)
17. F.O. Martinez, A. Sica, A. Mantovani, M. Locati Macrophage activation and polarization Front Biosci 13 2008 453 461 (Pubitemid 351599757)
18. R. Bagheri, A.N. Qasim, N.N. Mehta Relation of plasma fatty acid binding proteins 4 and 5 with the metabolic syndrome, inflammation and coronary calcium in patients with type-2 diabetes mellitus Am J Cardiol 106 2010 1118 1123
19. T.D. Schmittgen, K.J. Livak Analyzing real-time PCR data by the comparative C(T) method Nat Protoc 3 2008 1101 1108 (Pubitemid 351818697)
20. H. Shen, L.F. Bielak, J.F. Ferguson Association of the vitamin D metabolism gene CYP24A1 with coronary artery calcification Arterioscler Thromb Vasc Biol 30 2010 2648 2654
21. B.J. Keating, S. Tischfield, S.S. Murray Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies PLoS One 3 2008 e3583
22. C.J. Willer, Y. Li, G.R. Abecasis METAL: fast and efficient meta-analysis of genomewide association scans Bioinformatics 26 2010 2190 2191
23. Center for Statistical Genetics METAL: Meta Analysis Helper [software program] http://www.sph.umich.edu/csg/abecasis/Metal Accessed January 2010
24. M.P. Reilly, M. Li, J. He Myocardial Infarction Genetics Consortium and Wellcome Trust Case Control Consortium Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies Lancet 377 2011 383 392
25. D.R. Nyholt A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other Am J Hum Genet 74 2004 765 769 (Pubitemid 38420107)
26. N.N. Mehta, F.C. McGillicuddy, P.D. Anderson Experimental endotoxemia induces adipose inflammation and insulin resistance in humans Diabetes 59 2010 172 181
27. S. Fowler Characterization of foam cells in experimental atherosclerosis Acta Med Scand Suppl 642 1980 151 158
28. E.L. Heinzen, D. Ge, K.D. Cronin Tissue-specific genetic control of splicing: implications for the study of complex traits PLoS Biol 6 2008 e1
29. A.C. Nica, L. Parts, D. Glass MuTHER Consortium The architecture of gene regulatory variation across multiple human tissues: the MuTHER study PLoS Genet 7 2011 e1002003
30. 2 is protective from coronary artery disease in South Korean males PLoS One 6 2011 e18208
31. Q. Wang, Y. Hao, X. Mo PLA2G7 gene polymorphisms and coronary heart disease risk: a meta-analysis Thromb Res 126 2010 498 503
32. Y. Miwa, K. Kamide, S. Takiuchi Association of PLA2G7 polymorphisms with carotid atherosclerosis in hypertensive Japanese Hypertens Res 32 2009 1112 1118
33. J. Zacho, A. Tybjaerg-Hansen, J.S. Jensen, P. Grande, H. Sillesen, B.G. Nordestgaard Genetically elevated C-reactive protein and ischemic vascular disease N Engl J Med 359 2008 1897 1908
34. P. Elliott, J.C. Chambers, W. Zhang Genetic loci associated with C-reactive protein levels and risk of coronary heart disease JAMA 302 2009 37 48
35. R.A. Memon, J. Fuller, A.H. Moser, K.R. Feingold, C. Grunfeld In vivo regulation of plasma platelet-activating factor acetylhydrolase during the acute phase response Am J Physiol 277 1999 R94 R103
36. D.M. Stafforini, L.W. Tjoelker, S.P. McCormick Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein J Biol Chem 274 1999 7018 7024
37. B. Atik, S.C. Johnston, D. Dean Association of carotid plaque Lp-PLA(2) with macrophages and Chlamydia pneumoniae infection among patients at risk for stroke PLoS One 5 2010 e11026
38. X. Wu, T.M. McIntyre, G.A. Zimmerman, S.M. Prescott, D.M. Stafforini Molecular characterization of the constitutive expression of the plasma platelet-activating factor acetylhydrolase gene in macrophages Biochem J 375 2003 351 363 (Pubitemid 37315443)
39. K.L. Carpenter, I.F. Dennis, I.R. Challis Inhibition of lipoprotein-associated phospholipase A2 diminishes the death-inducing effects of oxidised LDL on human monocyte-macrophages FEBS Lett 505 2001 357 363 (Pubitemid 32905477)
40. C.M. Ballantyne, R.C. Hoogeveen, H. Bang Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study Circulation 109 2004 837 842 (Pubitemid 38252734)
41. C.J. Packard, D.S. O'Reilly, M.J. Caslake West of Scotland Coronary Prevention Study Group Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease N Engl J Med 343 2000 1148 1155
42. J.P. Casas, E. Ninio, A. Panayiotou PLA2G7 genotype, lipoprotein- associated phospholipase A2 activity, and coronary heart disease risk in 10 494 cases and 15 624 controls of European Ancestry Circulation 121 2010 2284 2293
43. M.A. Corson, P.H. Jones, M.H. Davidson Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker Am J Cardiol 101 2008 41F 50F
44. W. Koenig, N. Khuseyinova Lipoprotein-associated and secretory phospholipase A2 in cardiovascular disease: the epidemiological evidence Cardiovasc Drugs Ther 23 2009 85 92
45. M. Persson, J.A. Nilsson, J.J. Nelson, B. Hedblad, G. Berglund The epidemiology of Lp-PLA(2): distribution and correlation with cardiovascular risk factors in a population-based cohort Atherosclerosis 190 2007 388 396 (Pubitemid 46074030)
46. S. Suchindran, D. Rivedal, J.R. Guyton Genome-wide association study of Lp-PLA(2) activity and mass in the Framingham Heart Study PLoS Genet 6 2010 e1000928
47. J.A. Rumberger, R.S. Schwartz, D.B. Simons, P.F. Sheedy 3rd, W.D. Edwards, L.A. Fitzpatrick Relation of coronary calcium determined by electron beam computed tomography and lumen narrowing determined by autopsy Am J Cardiol 73 1994 1169 1173 (Pubitemid 24184389)
48. G.T. Kondos, J.A. Hoff, A. Sevrukov Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults Circulation 107 2003 2571 2576 (Pubitemid 36628938)